Related Experiment Video
Updated: Jul 20, 2026
09:39
Quantitative Immunofluorescence Assay to Measure the Variation in Protein Levels at Centrosomes
Published on: December 20, 2014
Intensity-based signal separation algorithm for accurate quantification of clustered centrosomes in tissue sections.
Markus C Fleisch1, Christopher A Maxwell, Claudia K Kuper
1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA.
Microscopy Research and Technique
|August 31, 2006
Summary
Centrosome abnormalities (CAs) are common in tumors. This study introduces a new optical method to accurately quantify CA in tissue sections, revealing 20-30% of cells in Tp53 null mammary tumors exhibit amplified centrosomes.
Area of Science:
- Cell Biology
- Cancer Research
- Biophysics
Background:
- Centrosomes are vital organelles regulating cell division, shape, and polarity.
- Centrosome abnormalities (CAs) are early events in epithelial and hematological tumors, linked to chromosomal instability and disease progression.
- Accurate quantification of CAs in situ is challenging due to organelle clustering and overlap in standard microscopy.
Purpose of the Study:
- To develop and validate a novel optical approach for precise in situ quantification of centrosome frequencies in tissue sections.
- To establish a method for estimating the proportion of cells with CAs, independent of background noise and traditional analysis limitations.
- To investigate the frequency of centrosome amplification in Tp53-null mammary tumors.
Main Methods:
- Utilized simple optical rules on non-deconvolved, conventional 3D images of stained tissue sections.
- Developed a technique to accurately quantify centrosome frequencies per nucleus, overcoming limitations of visual analysis and threshold-based methods.
- Integrated baseline centrosome amplification and proliferation rates to approximate the percentage of cells with CAs.
Main Results:
- The new optical method provides more accurate and rapid quantification of centrosome frequencies compared to traditional techniques.
- The approach successfully estimates the proportion of cells with CAs within tissue populations.
- Demonstrated that 20-30% of cells exhibit amplified centrosomes in Tp53 null mammary tumors.
Conclusions:
- The developed optical method offers a robust and efficient way to quantify centrosome frequencies and assess CAs in tumor tissues.
- This technique facilitates a deeper understanding of the role of CAs in cancer development, particularly in relation to Tp53 status.
- The findings highlight a significant prevalence of centrosome amplification in Tp53-deficient mammary tumors, suggesting potential therapeutic targets.
